XML 39 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Investment Securities
12 Months Ended
Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
Investment Securities
Note 3    Investment Securities
Investment securities include investment securities available for sale, marketable equity securities, and investment securities held to maturity. The investment securities portfolio consisted of the following at the dates indicated (in thousands):
December 31, 2021
 Amortized CostGross Unrealized
Carrying Value (1)
 GainsLosses
Investment securities available for sale:
U.S. Treasury securities$114,385 $173 $(2,898)$111,660 
U.S. Government agency and sponsored enterprise residential MBS
2,093,283 12,934 (8,421)2,097,796 
U.S. Government agency and sponsored enterprise commercial MBS
861,925 5,287 (10,313)856,899 
Private label residential MBS and CMOs
2,160,136 3,575 (14,291)2,149,420 
Private label commercial MBS
2,604,690 7,843 (8,523)2,604,010 
Single family real estate-backed securities474,845 5,031 (2,908)476,968 
Collateralized loan obligations1,079,217 598 (1,529)1,078,286 
Non-mortgage asset-backed securities151,091 1,419 — 152,510 
State and municipal obligations205,718 16,559 — 222,277 
SBA securities184,296 2,027 (2,728)183,595 
9,929,586 $55,446 $(51,611)9,933,421 
Investment securities held to maturity10,000 10,000 
$9,939,586 9,943,421 
Marketable equity securities 120,777 
$10,064,198 
December 31, 2020
 Amortized CostGross Unrealized
Carrying Value (1)
 GainsLosses
Investment securities available for sale:
U.S. Treasury securities$79,919 $1,307 $(375)$80,851 
U.S. Government agency and sponsored enterprise residential MBS
2,389,450 19,148 (3,028)2,405,570 
U.S. Government agency and sponsored enterprise commercial MBS
531,724 9,297 (1,667)539,354 
Private label residential MBS and CMOs
982,890 16,274 (561)998,603 
Private label commercial MBS(2)
2,514,271 24,931 (12,848)2,526,354 
Single family real estate-backed securities636,069 14,877 (58)650,888 
Collateralized loan obligations1,148,724 285 (8,735)1,140,274 
Non-mortgage asset-backed securities246,597 6,898 (234)253,261 
State and municipal obligations213,743 21,966 — 235,709 
SBA securities233,387 2,093 (3,935)231,545 
 8,976,774 $117,076 $(31,441)9,062,409 
Investment securities held to maturity10,000 10,000 
$8,986,774 9,072,409 
Marketable equity securities 104,274 
$9,176,683 
(1)At fair value except for securities held to maturity.
(2)Amortized cost is net of ACL totaling $0.4 million at December 31, 2020.
Investment securities held to maturity at December 31, 2021 and 2020 consisted of one State of Israel bond maturing in 2024. Accrued interest receivable on investments totaled $16 million and $17 million at December 31, 2021 and 2020, respectively, and is included in other assets in the accompanying consolidated balance sheets.
At December 31, 2021, contractual maturities of investment securities available for sale, adjusted for anticipated prepayments when applicable, were as follows (in thousands):
Amortized CostFair Value
Due in one year or less$1,651,375 $1,646,232 
Due after one year through five years5,915,112 5,929,475 
Due after five years through ten years1,933,775 1,929,493 
Due after ten years429,324 428,221 
 $9,929,586 $9,933,421 
The carrying value of securities pledged as collateral for FHLB advances, public deposits, interest rate swaps and to secure borrowing capacity at the FRB totaled $4.0 billion and $4.1 billion at December 31, 2021 and 2020, respectively.
The following table provides information about gains and losses on investment securities for the periods indicated (in thousands):
Years Ended December 31,
 202120202019
Proceeds from sale of investment securities AFS$2,286,600 $1,503,498 $2,975,259 
Gross realized gains on investment securities AFS$10,005 $14,441 $21,961 
Gross realized losses on investment securities AFS(995)(440)(3,424)
Net realized gain9,010 14,001 18,537 
Net unrealized gains (losses) on marketable equity securities recognized in earnings(2,564)3,766 2,637 
Gain on investment securities, net$6,446 $17,767 $21,174 
The following tables present the aggregate fair value and the aggregate amount by which amortized cost exceeded fair value for investment securities available for sale in unrealized loss positions aggregated by investment category and length of time that individual securities had been in continuous unrealized loss positions at the dates indicated (in thousands):
 December 31, 2021
 Less than 12 Months12 Months or GreaterTotal
 Fair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized Losses
U.S. Treasury securities
$49,328 $(591)$47,102 $(2,307)$96,430 $(2,898)
U.S. Government agency and sponsored enterprise residential MBS
436,744 (4,549)401,022 (3,872)837,766 (8,421)
U.S. Government agency and sponsored enterprise commercial MBS
247,323 (4,084)163,380 (6,229)410,703 (10,313)
Private label residential MBS and CMOs
1,552,946 (13,933)23,355 (358)1,576,301 (14,291)
Private label commercial MBS
1,338,288 (6,085)171,490 (2,438)1,509,778 (8,523)
Single family real estate-backed securities154,552 (2,908)— — 154,552 (2,908)
Collateralized loan obligations318,555 (445)319,192 (1,084)637,747 (1,529)
SBA securities496 — 99,599 (2,728)100,095 (2,728)
 $4,098,232 $(32,595)$1,225,140 $(19,016)$5,323,372 $(51,611)
 December 31, 2020
 Less than 12 Months12 Months or GreaterTotal
 Fair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized Losses
U.S. Treasury securities
$24,369 $(375)$— $— $24,369 $(375)
U.S. Government agency and sponsored enterprise residential MBS
220,179 (320)370,727 (2,708)590,906 (3,028)
U.S. Government agency and sponsored enterprise commercial MBS
152,233 (1,412)44,255 (255)196,488 (1,667)
Private label residential MBS and CMOs
141,407 (561)— — 141,407 (561)
Private label commercial MBS
1,268,381 (12,771)37,783 (77)1,306,164 (12,848)
Single family real estate-backed securities28,758 (58)— — 28,758 (58)
Collateralized loan obligations304,051 (1,171)588,463 (7,564)892,514 (8,735)
Non-mortgage asset-backed securities
— — 12,327 (234)12,327 (234)
SBA securities26,240 (298)104,598 (3,637)130,838 (3,935)
 $2,165,618 $(16,966)$1,158,153 $(14,475)$3,323,771 $(31,441)
The Company monitors its investment securities available for sale for credit loss impairment on an individual security basis. No securities were determined to be credit loss impaired during the year ended December 31, 2021. An ACL was recorded related to one private label commercial MBS security during the year ended December 31, 2020. At December 31, 2021, the Company did not have an intent to sell securities that were in unrealized loss positions and it was not more likely than not that the Company would be required to sell these securities before recovery of the amortized cost basis, which may be at maturity. In making this determination, the Company considered its current and projected liquidity position, its investment policy as to permissible holdings and concentration limits, regulatory requirements and other relevant factors.
At December 31, 2021, 244 securities available for sale were in unrealized loss positions. The unrealized losses are primarily attributable to changes in interest rates and widening spreads, signaling market anticipation of changes in monetary policy. The amount of impairment related to 72 of these securities was considered insignificant both individually and in the aggregate, totaling approximately $0.6 million and no further analysis with respect to these securities was considered necessary.
For U.S. Government, U.S. government agency and U.S. government sponsored enterprise securities, the timely payment of principal and interest is explicitly or implicitly guaranteed by the U.S. Government. As such, there is an assumption of zero credit loss and the Company expects to recover the entire amortized cost basis of these securities. For all other AFS securities in a significant unrealized loss position, the Company performed an analysis by first determining the present value of cash flows expected to be collected, based on an economic scenario calibrated to be more severe than our reasonable and supportable economic forecast. The present value was then compared to the amortized cost basis to identify possible impairment. The analysis incorporated assumptions about voluntary prepayment rates, collateral defaults, delinquencies, severity, recovery lag and other relevant factors. Our analysis also considered the structural characteristics of each security and the level of credit enhancement provided by that structure.